Prospective use of free PSA to avoid repeat prostate biopsies in men with elevated total PSA

Prostate

Volumn 29, Issue SUPPL. 7, 1996, Pages 58-63

  Morgan, Ted O ^a   McLeod, David G ^a,c   Leifer, Eric S ^a   Moul, Judd W ^a,c   Murphy, Gerald P ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NORTHWEST HOSPITAL   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

free PSA; prostate; prostate specific antigen; screening

Indexed keywords

ADULT; AGED; ANTIGEN DETECTION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; STATISTICS; ARTICLE; BIOPSY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; PROSTATE; REOPERATION; ROC CURVE;

PROSTATE SPECIFIC ANTIGEN;

AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; REOPERATION; ROC CURVE;

EID: 0030334124     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(1996)7+<58::AID-PROS8>3.0.CO;2-F     Document Type: Conference Paper

References (24)

1. Catalona WJ, Smith DS, Ratliff TL, Basler JW: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270:948-954, 1993.
2. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH: Screening for prostatic carcinoma with prostate specific antigen. J Urol 147:841-845, 1992.
3. Mettlin C, Murphy GP, Lee F, Littrup PJ, Chesley A, Babaian R, Badalament R, Kane RA, Mostofi FK: Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project. Cancer 72:1701-1708, 1993.
4. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics 1996. CA 46:5-27, 1996.
5. Woolf SH: Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. N Engl J Med 333:1401-1405, 1995.
6. Walsh PC: Using prostate-specific antigen to diagnose prostate cancer: Sailing in uncharted waters. Ann Intern Med 119:948-949, 1993.
7. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, de Kernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC: Comparison of digital rectal exam and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6630 men. J Urol 151:1283-1290, 1994.
8. Benson MC, Whang IS, Pantuck AW, Ring K, Kaplan SA, Olsson CA, Cooner WH: Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147:815-816, 1992.
9. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 147:817-321, 1992.
10. Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267:2215-2220, 1992.
11. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA 270:860-864, 1993.
12. Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DS, McLeod DG, Moul JW: Age-specific reference ranges for prostate-specific antigen in Black men. N Engl J Med 335:304-310, 1996.
13. Christensson A, Laurell CB, Lilja H: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 194:755-763, 1990.
14. Lilja H, Christensson A, Dahlen U, Matikinen MT, Nilsson O, Pettersson K, Lovgren T: Prostate specific antigen in serum occurs predominately in complex with alpha-1-antichymotrypsin. Clin Chem 37:1618-1625, 1991.
15. Stenman U-H, Leinaon J, Alfthan H, Rannikko S, Tuhkaren K, Alfthan O: A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate specific antigen in serum of patients with prostate cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res 51:222-226, 1991.
16. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36, 1982.
17. Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839-843, 1983.
18. Woolson RF: "Statistical Methods for the Analysis of Biomedical Data." New York: John Wiley & Sons, 1987.
19. Keetch DW, Catalona WJ, Smith DS: Serial prostate biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 151:1571-1574, 1994.
20. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Raflif TL, Nadler RB: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274:1214-1220, 1995.
21. Luderer AA, Chen Y, Soriano TF, Kramp WJ, Carlson G, Cuny C, Sharp T, Smith W, Petteway J, Brawer MK, Thiel R: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 46:187-194, 1995.
22. Bazinet M, Karkiewicz PI, Aprikian AG, Trudel C, Aronson S, Nachabe M, Peloquin F, Dessureault J, Goyal M, Zheng W, Begin LR, Elhilali MM: Value of systematic transition zone biopsies in the early detection of prostate cancer. J Urol 155:605-606, 1996.
23. Keetch DW, Catalona WJ: Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values. J Urol 154:1795-1797, 1995.
24. Oesterling JE, Jacobsen SJ, Klee GG, Pettersson K, Piironen T, Abrahamsson PA, Stenman UH, Doweli B, Lovgren T, Lilja H: Free, complexed and total serum prostate specific antigen: The establishment of appropriate reference ranges for their concentrations and ratios. J Urol 154:1090-1095, 1995.